Clinical Trial Update: A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 study to compare QLS31905 plus chemotherapy versus placebo plus chemotherapy in pancreatic cancer; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• QLS31905

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Pancreatic Cancer | Phase 3 | Status: RECRUITING